Jeffrey Takahiro Means, DO
Hematology/Oncology · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Means’s office at (916) 688-2000 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$105,102
Pharmacies billed $105,102 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (11 of 158) in 2024. Above the middle of the specialty; the typical student in an organized health care education/training program clinician is at 0%.
140 generic and 18 brand-name prescriptions · $105,102 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lidocaine-Prilocaine | 11 | $253 | $21 |
| Prednisone | 13 | $231 | $8 |
Year by year
| 2024 | 158 | 48 | 7% (11) | 11% | $105,102 |
| 2021 | 66 | 24 | 0% (0) | None | $6,800 |
| 2020 | 73 | 37 | 0% (0) | None | $3,619 |
| 2019 | 37 | 21 | 0% (0) | None | $1,182 |
| 2018 | 13 | None | 0% (0) | None | $136 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$319 in 2024
| 2024 | 8 | 10 | None | $319 |
| 2023 | 10 | 12 | None | $388 |
| 2022 | 6 | 9 | None | $554 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Jemperli | $118 | 1 payment
|
| Novartis Pharmaceuticals | Scemblix | $51 | 2 payments
|
| EMD Serono | None | $34 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $30 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Iclusig | $27 | 1 payment
|
| Pfizer | Padcev | $24 | 1 payment
|
See all 10 published payments
| Pfizer | Meals · 2024-06-13 | Padcev | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2024-06-07 | Tagrisso | $17 |
| EMD Serono | Meals · 2024-05-02 | None | $20 |
| Astellas Pharma US | Meals · 2024-04-18 | Xtandi | $17 |
| GlaxoSmithKline | Meals · 2024-04-17 | Jemperli | $118 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2024-04-04 | Iclusig | $27 |
| Novartis Pharmaceuticals | Meals · 2024-03-28 | Scemblix | $29 |
| Merck Sharp & Dohme | Meals · 2024-03-07 | Keytruda | $30 |
| EMD Serono | Meals · 2024-02-28 | None | $15 |
| Novartis Pharmaceuticals | Meals · 2024-01-25 | Fabhalta | $23 |
See earlier years (2023, 2022)
2023: $388
| Seagen | Tivdak | $129 | 2 payments
|
| Myriad Genetic Laboratories | Precisetumor | $45 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Tagrisso | $43 | 2 payments
|
| TerSera Therapeutics | Xermelo | $30 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Iclusig | $30 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $28 | 1 payment
|
| Daiichi Sankyo | Injectafer | $26 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $24 | 1 payment
|
| Amgen | Lumakras | $21 | 1 payment
|
| Pfizer | Ibrance | $13 | 1 payment
|
2022: $554
| Pharmacosmos Therapeutics | Monoferric | $126 | 3 payments
|
| GlaxoSmithKline | Blenrep | $122 | 1 payment
|
| Eisai | Lenvima | $114 | 1 payment
|
| Astellas Pharma US | Padcev | $102 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | None | $74 | 1 payment
|
| Daiichi Sankyo | Injectafer | $16 | 1 payment
|
Professional record
- NPI
- 1518460336
- Trained
- Touro Un College of Osteopathic Medicine, Vallejo, 2018
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Student in a training program (390200000X)
- Mailing address
- 710 Lawrence Expy, Santa Clara, CA, 95051
- NPI first listed
- 2018-03-18
- NPI last updated
- 2018-03-18
This is when the NPI record was last certified, not a medical board exam.